Valuation : Dil Ltd

Market Cap 1.42TCr 15Cr 15Cr 13Cr 12Cr 11Cr 21Cr 21Cr 142.92Cr 55Cr 721.48Cr 56Cr 55Cr 2.29TCr P/E 2025
10.4x
P/E 2026 13x
Enterprise Value 1.5TCr 16Cr 16Cr 14Cr 13Cr 12Cr 22Cr 22Cr 151.05Cr 58Cr 762.53Cr 59Cr 58Cr 2.42TCr EV / Sales 2025
1.81x
EV / Sales 2026 1.94x
Free-Float
28.52%
Yield 2025
0.91%
Yield 2026 1.18%
Manager TitleAgeSince
Chief Executive Officer 56 09/05/2021
Director of Finance/CFO - 16/02/2017
Compliance Officer - 12/02/2024
Director TitleAgeSince
Director/Board Member 44 22/06/2011
Director/Board Member 75 29/12/2009
Director/Board Member 57 24/10/1994
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-5.47%+44.72%-3.37% 8.09TCr
-2.05%-0.64%-19.76%-36.79% 6.05TCr
-2.91%-9.53%+457.58%+28.96% 5.6TCr
+0.83%-4.47%-8.40%+30.44% 4.96TCr
-1.11%-7.21%-2.15%+148.24% 4.59TCr
-0.62%-5.03%+47.26%-18.33% 3.14TCr
+1.68%-1.61%+48.07%+96.79% 2.52TCr
-2.00%-3.35%-2.29%+177.79% 2.22TCr
-3.02%-2.59%+60.23%+99.82% 1.66TCr
Average -1.09%-1.29%+69.47%+58.17% 4.32TCr
Weighted average by Cap. -1.07%-1.13%+80.31%+38.40%

Financials

2025 2026
Net sales 469.48Cr 4.93Cr 4.93Cr 4.25Cr 4Cr 3.64Cr 6.82Cr 6.84Cr 47Cr 18Cr 239.18Cr 19Cr 18Cr 757.72Cr 525.43Cr 5.52Cr 5.52Cr 4.75Cr 4.47Cr 4.08Cr 7.63Cr 7.66Cr 53Cr 20Cr 267.68Cr 21Cr 20Cr 848.02Cr
Net income 77Cr 80.77L 80.77L 69.51L 65.45L 59.63L 1.12Cr 1.12Cr 7.76Cr 3Cr 39Cr 3.03Cr 2.97Cr 124.05Cr 72Cr 75.42L 75.42L 64.9L 61.11L 55.68L 1.04Cr 1.05Cr 7.24Cr 2.8Cr 37Cr 2.83Cr 2.77Cr 115.83Cr
Net Debt 44Cr 46.53L 46.53L 40.04L 37.7L 34.35L 64.27L 64.53L 4.47Cr 1.73Cr 23Cr 1.75Cr 1.71Cr 71Cr 81Cr 84.67L 84.67L 72.86L 68.61L 62.51L 1.17Cr 1.17Cr 8.13Cr 3.14Cr 41Cr 3.18Cr 3.11Cr 130.04Cr
Logo Dil Ltd
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. It is also engaged in renting and selling properties. Its segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. It has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and others. It provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, and vitamin AD2 premix, among others.
Employees
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!